retatrutide phase 2 trial obesity nejm 2023 Dosing Guide: 1-12 mg Weekly Triple Agonist (2026) Triple hormone receptor agonist retatrutide
Description
Typically, Tirzepatide is dosed once a week
Based on the available evidence, there is currently no strong clinical evidence demonstrating meaningful weight loss from GLP-1 patches
Under physiological conditions, GLP- 1 is rapidly degraded by dipeptidyl peptidase-4 (DPP- 4) after it is released (7)
North America currently leads the global GLP-1 analogue market, driven by high obesity rates, strong reimbursement frameworks, and proactive healthcare systems
One of the medications for managing Type 2 diabetes currently available in South Africa is Mounjaro
One is that they have lost a lot of market share in the U.S., which is the biggest pharmaceutical market in the world
